Pacira BioSciences, Inc.
PCRX· Nasdaq
Released May 2, 2019, during market hours
10-Q filed May 2, 2019, 32 days after period end · 0001396814-19-000014
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2019 | Q1 2018 | Q1 2017 | Q1 2016 |
|---|---|---|---|---|
| Revenue | $90.91M | $74.29M | $68.43M | $65.47M |
| Net Income | -$2.77M | -$10.68M | -$19.87M | -$3.85M |
| EPS Diluted | -$0.07 |
Pacira BioSciences, Inc. · CIK 1396814 · Engraved from SEC EDGAR
| -$0.26 |
| -$0.52 |
| -$0.10 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.